PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 268 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,660,323 | -39.4% | 151,901 | -20.8% | 0.03% | -41.1% |
Q2 2023 | $7,689,473 | +13.8% | 191,901 | +6.7% | 0.06% | +19.1% |
Q1 2023 | $6,757,568 | -38.9% | 179,901 | -20.7% | 0.05% | -37.3% |
Q4 2022 | $11,055,766 | +15.5% | 226,911 | +26.1% | 0.08% | +11.9% |
Q3 2022 | $9,569,000 | +26.4% | 179,901 | +38.5% | 0.07% | +8.1% |
Q2 2022 | $7,573,000 | -43.0% | 129,901 | -25.4% | 0.06% | -31.1% |
Q1 2022 | $13,285,000 | -4.0% | 174,081 | -24.3% | 0.09% | +2.3% |
Q4 2021 | $13,844,000 | +20.6% | 230,081 | +12.3% | 0.09% | +12.8% |
Q3 2021 | $11,477,000 | +706.0% | 204,960 | +361.2% | 0.08% | +239.1% |
Q2 2018 | $1,424,000 | +2.9% | 44,440 | 0.0% | 0.02% | -4.2% |
Q1 2018 | $1,384,000 | -35.5% | 44,440 | -5.4% | 0.02% | -35.1% |
Q4 2017 | $2,146,000 | +7.8% | 47,000 | -11.3% | 0.04% | +5.7% |
Q3 2017 | $1,990,000 | -21.3% | 53,000 | 0.0% | 0.04% | -27.1% |
Q2 2017 | $2,528,000 | -7.6% | 53,000 | -11.7% | 0.05% | -9.4% |
Q1 2017 | $2,736,000 | -14.3% | 60,000 | +66.7% | 0.05% | -20.9% |
Q4 2014 | $3,192,000 | – | 36,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,799,916 | $121,768,000 | 8.62% |
Tamarack Advisers, LP | 625,000 | $27,044,000 | 8.22% |
NEXTHERA CAPITAL LP | 149,086 | $6,484,000 | 5.40% |
Spyglass Capital Management LLC | 379,609 | $16,509,000 | 5.22% |
Gagnon Advisors, LLC | 107,412 | $4,671,000 | 2.67% |
GAGNON SECURITIES LLC | 278,613 | $12,117,000 | 2.61% |
Asymmetry Capital Management, L.P. | 84,735 | $3,685,000 | 2.00% |
Rock Springs Capital Management LP | 1,250,000 | $54,363,000 | 1.97% |
Lisanti Capital Growth, LLC | 118,620 | $5,159,000 | 1.68% |
Elk Creek Partners, LLC | 500,069 | $21,748,000 | 1.62% |